跳至主要内容
临床试验/DRKS00024854
DRKS00024854已完成不适用

Investigation of trends in the provision of opioid analgesics for non-cancer pain - Op-US

ehrstuhl für Medizinmanagement, Universität Duisburg-Essen0 个研究点目标入组 1,152 人开始时间: 2021年4月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Guideline Interviews with General Practitioners and Specialists:
  • Physicians with advanced training in orthopedics and/or trauma surgery as well as neurology, general practitioners, internists, and pain physicians.
  • Written survey of insureds:
  • - No change of insurance in the period 1/1/2019-31/03/2020 (insurance with DAK Gesundheit).
  • Up to 5 days of absence at a stretch are accepted. Persons who meet the above criteria and deceased in the period under consideration are included.
  • - At least one prescription per quarter of opioid analgesics in Q1 and Q2 2020. If there are prescriptions only in Q1 and Q2 2020, there must be at least 90 days between the first and the last prescription date.
  • - Coding a diagnosis in one of the quarters in 2020 regarding:
  • - Chronic back pain: ICD-10-GM M42.16-M42.19, M42.90, M42.96-99, M43.0, M43.1, M47.26, M47.27, M47.29, M47.86, M47.87, M47.88, M47.99, M48.06, M48.2, M54.16, M54.5, M55.3, M.99.33; M99.43, M99.53.
  • - Arthritis pain: ICD-10-GM M15-M19
  • Age > 17 years in Q1 2020: date of birth 1/1/2002 and before.
  • Care epidemiology based on routine data:
  • - No change of insurance in the period 1/1/2017-31/03/2021 (insurance with DAK Gesundheit). Up to 5 days of absence at a stretch are accepted. Persons who meet the above criteria and deceased in the period under consideration are included.
  • - At least one prescription per quarter of opioid analgesics in at least 2 consecutive quarters. If there are prescriptions in only 2 consecutive quarters, there must be at least 90 days between the first and last date of prescription . A first prescription must be between Q1 2018 and Q1 2019.
  • - Age > 17 years in the quarter of the first prescription of an opioid analgesic within the selection peroid (Q1 2018- Q1 2019)
  • Stakeholder Interviews:
  • The decision on which stakeholder groups to interview will be made during the course of the project based on previous project findings.

排除标准

  • Written survey of insureds:
  • Diagnosis of a malignant neoplasm in one of the quarters in 2020:
  • ICD-10-GM: C00-C97 with the endings G and Z or no ending.
  • Evidence of palliative care in one of the quarters in 2020:
  • - ICD-10-GM: Z51.5
  • - EBM: 01425 to 01426, 03370 to 03373, 04370 to 04373, 37300 to 37320
  • - DRG: ZE60, ZE145, ZE2020-133, ZE2020-134
  • - OPS: 8-982, 8-98e, 8-98h, 1-265.b, 1-773, 1-774
  • Care epidemiology based on routine data:
  • Diagnosis of a malignant neoplasm in one of at least two consecutive quarters of prescription of an opioid analgesic: ICD-10-GM: C00-C97 with the endings G and Z (outpatient) or no ending (inpatient).
  • Evidence of palliative care in one of at least 2 consecutive quarters of prescription of opioid analgesic
  • - ICD-10-GM: Z51.5
  • - EBM: 01425 to 01426, 03370 to 03373, 04370 to 04373, 37300 to 37320
  • - DRG: ZE60, ZE145, ZE2020-133, ZE2020-134
  • - OPS: 8-982, 8-98e, 8-98h, 1-265.b, 1-773, 1-774

研究者

发起方
ehrstuhl für Medizinmanagement, Universität Duisburg-Essen

相似试验